Mid-Morning Market Update: Markets Open Lower; Halliburton Profit Beats Estimates
Following the market opening Monday, the Dow traded down 1.95% to 33,598.00 while the NASDAQ fell 2.59% to 13,412.35. The S&P also fell, dropping, 2.29% to 4,297.14.
Benzinga Pro’s Top 5 Stocks To Watch For Monday, Jan. 24, 2022: UL, SNAP, OPK, M, IBM
Today's 5 Stock Ideas:
Unilever (UL) - Shares rose following a media report that hedge fund Trian Partners has built a stake in the company.
Snap (SNAP) - Wedbush downgraded the stock from Outperform to
28 Stocks Moving in Monday’s Pre-Market Session
Gainers
BT Brands, Inc. (NASDAQ: BTBD) shares rose 158% to $6.37 in pre-market trading after declining around 12% on Friday.
Activist Investor Nelson Peltz’s Fund Buys Stake In Unilever: FT
Trian Fund Management LP, the activist hedge fund run by Nelson Peltz, has built a stake in Unilever PLC (NYSE: UL), the Financial Times reports, citing people with direct knowledge of the matter.
Financial Times Reported Nelson Peltz’s Trian Partners has Built a Stake in Unilever
https://www.ft.com/content/a17a6811-78a8-4eb7-a2be-adbb8eb75119
Mid-Afternoon Market Update: Dow Tumbles 150 Points; Yumanity Therapeutics Shares Plunge
Toward the end of trading Wednesday, the Dow traded down 0.45% to 35,210.04 while the NASDAQ fell 0.28% to 14,466.47. The S&P also fell, dropping, 0.29% to 4,563.94.
Mid-Day Market Update: US Stocks Turn Negative; Zogenix Shares Spike Higher
Midway through trading Wednesday, the Dow traded down 0.13% to 35,321.51 while the NASDAQ fell 0.53% to 14,430.41. The S&P also fell, dropping, 0.19% to 4,568.33.
GSK Spurns $68.4B Bid From Unilever For Its Consumer Healthcare Business, Opts to Spin-off The Unit
GlaxoSmithKline rejects three purchase offers from Unilever for its Consumer Healthcare business.
The U.K. pharma giant says the business is well-positioned to sustainably grow ahead of its categories in the years to come.